|
Oct 9
|
Syros Pharmaceuticals Inc (SYRS) Q2 2024 Earnings Call Highlights: Strategic Focus on ...
|
|
Aug 27
|
Syros Pharmaceuticals to Present at Upcoming Medical and Investor Conferences
|
|
Jun 17
|
Syros Pharmaceuticals, Inc.'s (NASDAQ:SYRS) high institutional ownership speaks for itself as stock continues to impress, up 17% over last week
|
|
Jun 13
|
Syros to Host Webcast Event on Higher-Risk Myelodysplastic Syndrome and the Opportunity for Tamibarotene to Become the New Frontline Standard-of-Care for Patients with RARA Gene Overexpression
|
|
Jan 19
|
Syros (SYRS) Stock Surges 200% in 3 Months: Here's Why
|
|
Jan 18
|
Are You Looking for a Top Momentum Pick? Why Syros Pharmaceuticals, Inc. (SYRS) is a Great Choice
|
|
Jan 17
|
Syros Pharmaceuticals, Inc. (SYRS) Is a Great Choice for 'Trend' Investors, Here's Why
|
|
Jan 16
|
What Makes Syros Pharmaceuticals, Inc. (SYRS) a New Buy Stock
|
|
Jan 16
|
Wall Street Analysts Predict a 199.31% Upside in Syros Pharmaceuticals, Inc. (SYRS): Here's What You Should Know
|
|
Jan 11
|
Why Syros Pharmaceuticals (SYRS) Stock Might be a Great Pick
|